$RSSS SEC Filings

Filed On	Filing
01 Oct 2026	ARS
01 Oct 2026	DEFA14A
01 Oct 2026	Proxy statement: annual meeting on November 16, 2026 CEO pay $556K, down 13% · say-on-pay vote
11 Sep 2026	10-K
09 Sep 2026	8-K: Results of Operations and Financial Condition Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million
03 Aug 2026	Form 4: Cohen Sefton, Chief Revenue Officer Returned 284,000 shares to the issuer ($625K)
03 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
15 May 2026	10-Q
14 May 2026	8-K: Results of Operations and Financial Condition
11 May 2026	SCHEDULE 13G/A
06 May 2026	Form 4: Cohen Sefton, Chief Revenue Officer Received 80,000 shares as a grant or award ($183K)
13 Feb 2026	10-Q
12 Feb 2026	8-K: Results of Operations and Financial Condition
22 Dec 2025	Form 4: Kutil David, CFO & Secretary Received 30,000 shares as a grant or award ($90K) · Gave up 758 shares to cover exercise price or tax ($2.19K)
22 Dec 2025	Form 3: Kutil David, CFO & Secretary No securities owned
16 Dec 2025	Form 4: Gayron Kenneth L, Director Granted 50,000 Option to purchase common stock
12 Dec 2025	Form 4: Mcpeak Merrill A, Director Received 75,000 shares by exercise or conversion ($52.5K) · Granted 50,000 Option to purchase common stock
11 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
21 Nov 2025	Form 4: Regazzi John J, Director Received 150,000 shares by exercise or conversion ($105K)
21 Nov 2025	Form 4: Regazzi John J, Director Granted 60,000 Option to purchase common stock

Comments